1. 15-3 or CA 27.29 as a routine surveillance test, Development Conference (November 2, 2000,
2. new drugs may result in improved survival. expert consensus panel on the primary therapy There are data to support that a small frac- of early breast cancer. J Clin Oncol 2003; 21:
3. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.
4. Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers